Head to head
CJC-1295 (no DAC) vs Ipamorelin
Two compounds, one grading system.
The human evidence base is comparable — the difference is in what each is studied for.
01
At a glance
IpamorelinEmerging
Selective growth-hormone secretagogue. Raises GH; downstream benefits less proven.
118publications
2RCTs
02
Side by side
| Attribute | CJC-1295 (no DAC) | Ipamorelin |
|---|---|---|
| Goal | Longevity | Muscle & performance |
| Evidence | Emerging | Emerging |
| Publications | 59 | 118 |
| Randomised trials | 2 | 2 |
| Sport (WADA) | S2 — prohibited | S2 — prohibited |
| US compounding | — | — |
03
Claims vs data
CJC-1295 (no DAC) — claims vs data
| Raises growth hormone and IGF-1 levels | supported |
| Builds muscle and burns fat in healthy adults | weak evidence |
| Long-term use is established as safe | overreach |
Ipamorelin — claims vs data
| Increases growth hormone release | supported |
| Produces meaningful muscle gain alone | weak evidence |